Contact this trialFirst, we need to learn more about you.
GLP-1 Receptor Agonist
Cagrilintide +2 More for Type 2 Diabetes
Recruiting2 awardsPhase 3
Toluca Lake, California
This trial will test how well a new medicine called CagriSema helps people with type 2 diabetes to lower their blood sugar and body weight. CagriSema is not yet approved
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.